Review explores the gut-brain axis in type 1 diabetes and obesity, examining how gut peptides including GLP-1 and GIP may influence T1D pathophysiology.
Key findingReview explores the gut-brain axis in type 1 diabetes and obesity, examining how gut peptides includ
What the researchers found
Review explores the gut-brain axis in type 1 diabetes and obesity, examining how gut peptides including GLP-1 and GIP may influence T1D pathophysiology.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
No specific numerical data — review of mechanisms and emerging evidence.
How the study worked
In publication.
Who was studied
People with type 1 diabetes and obesity
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: Terra Incognita?
Current obesity reports, 14(1), 61
Citation
Argyrakopoulou, Georgia; Gitsi, Evdoxia; Dalamaga, Maria; Kokkinos, Alexander. (2025). Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: Terra Incognita?. Current obesity reports, 14(1), 61. https://doi.org/10.1007/s13679-025-00654-8